Literature DB >> 18633606

Intestinal hyperabsorption of calcium and low bone turnover in hypercalciuric postmenopausal osteoporosis.

Clarita V Odvina1, John R Poindexter, Roy D Peterson, Joseph E Zerwekh, Charles Y C Pak.   

Abstract

Hypercalciuria of intestinal origin has been linked with bone loss in calcium nephrolithiasis and idiopathic osteoporosis. This retrospective data analysis was performed to explore potential pathogenetic link between intestinal hyperabsorption of calcium and postmenopausal osteoporosis. Data were retrieved from postmenopausal women who were evaluated for osteoporosis or osteopenia at the Mineral Metabolism Clinic of UT Southwestern Medical Center. A total of 319 patients underwent the test of calciuric response to oral calcium load to obtain an indirect measure of intestinal calcium absorption. Serum and urinary biochemistry and L2-L4 bone mineral density (BMD) were compared between five quintiles of calciuric response. There was a statistically significant trend toward a rise in 24-h urinary calcium and a decrease in urinary deoxypyridinoline (DPD) and BMD, with increasing order of quintiles. The presentation of those in the 1st quintile was consistent with vitamin D insufficiency or deficiency, with impaired calcium absorption, secondary hyperparathyroidism, and stimulated bone turnover (high normal urinary DPD). In contrast, patients in the 5th quintile displayed a picture of absorptive hypercalciuria of stone disease, with intestinal hyperabsorption of calcium, high or high normal urinary calcium and suppressed bone turnover (low or low normal urinary DPD). Thus, the assessment of intestinal calcium absorption in a seemingly homogeneous group of postmenopausal women with osteoporosis or osteopenia revealed a spectrum of calciuric response whose extremes may represent two physiologically distinct subtypes that have important diagnostic and therapeutic implications.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18633606     DOI: 10.1007/s00240-008-0146-4

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  31 in total

Review 1.  Vitamin D deficiency.

Authors:  Michael F Holick
Journal:  N Engl J Med       Date:  2007-07-19       Impact factor: 91.245

2.  The role of 1 alpha, 25-dihydroxyvitamin D in the mediation of intestinal hyperabsorption of calcium in primary hyperparathyroidism and absorptive hypercalciuria.

Authors:  R A Kaplan; M R Haussler; L J Deftos; H Bone; C Y Pak
Journal:  J Clin Invest       Date:  1977-05       Impact factor: 14.808

3.  A histomorphometric determination of iliac bone remodeling in patients with recurrent renal stone formation and idiopathic hypercalciuria.

Authors:  T Steiniche; L Mosekilde; M S Christensen; F Melsen
Journal:  APMIS       Date:  1989-04       Impact factor: 3.205

4.  Possible role of cytokines on the bone mineral loss in idiopathic hypercalciuria.

Authors:  J R Weisinger; E Alonzo; E Bellorín-Font; A M Blasini; M A Rodriguez; V Paz-Martínez; R Martinis
Journal:  Kidney Int       Date:  1996-01       Impact factor: 10.612

5.  Evidence for disordered control of 1,25-dihydroxyvitamin D production in absorptive hypercalciuria.

Authors:  A E Broadus; K L Insogna; R Lang; A F Ellison; B E Dreyer
Journal:  N Engl J Med       Date:  1984-07-12       Impact factor: 91.245

6.  Mechanism and function of high vitamin D receptor levels in genetic hypercalciuric stone-forming rats.

Authors:  Alexander J Karnauskas; Johannes P T M van Leeuwen; Gert-Jan C M van den Bemd; Paru P Kathpalia; Hector F DeLuca; David A Bushinsky; Murray J Favus
Journal:  J Bone Miner Res       Date:  2004-11-29       Impact factor: 6.741

7.  Bone density and skeletal metabolism are altered in idiopathic hypercalciuria.

Authors:  S Giannini; M Nobile; L Sartori; L Calò; A Tasca; L Dalle Carbonare; M Ciuffreda; A D'Angelo; F Pagano; G Crepaldi
Journal:  Clin Nephrol       Date:  1998-08       Impact factor: 0.975

8.  Bone disease in calcium stone forming patients.

Authors:  I P Heilberg; L A Martini; V L Szejnfeld; A B Carvalho; S A Draibe; H Ajzen; O L Ramos; N Schor
Journal:  Clin Nephrol       Date:  1994-09       Impact factor: 0.975

9.  Bone mass loss in calcium stone disease: focus on hypercalciuria and metabolic factors.

Authors:  Renata Caudarella; Fabio Vescini; Angela Buffa; Giuseppe Sinicropi; Elisabetta Rizzoli; Gaetano La Manna; Sergio Stefoni
Journal:  J Nephrol       Date:  2003 Mar-Apr       Impact factor: 3.902

10.  Search for occult secondary osteoporosis: impact of identified possible risk factors on bone mineral density.

Authors:  H A Deutschmann; M Weger; W Weger; P Kotanko; M J Deutschmann; F Skrabal
Journal:  J Intern Med       Date:  2002-11       Impact factor: 8.989

View more
  2 in total

1.  The value of hypercalciuria in patients with osteopenia versus osteoporosis.

Authors:  María Sierra Girón-Prieto; María Del Carmen Cano-García; Antonio Poyatos-Andújar; Salvador Arias-Santiago; Tomás de Haro-Muñoz; Miguel Arrabal-Martín; Miguel Ángel Arrabal-Polo
Journal:  Urolithiasis       Date:  2016-08-01       Impact factor: 3.436

2.  Villin promoter-mediated transgenic expression of transient receptor potential cation channel, subfamily V, member 6 (TRPV6) increases intestinal calcium absorption in wild-type and vitamin D receptor knockout mice.

Authors:  Min Cui; Qiang Li; Robert Johnson; James C Fleet
Journal:  J Bone Miner Res       Date:  2012-10       Impact factor: 6.741

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.